Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lung Neoplasms × veliparib × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Small Cell Lung Carcinoma 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Glioma 1 Ependymoma 1

Interventions

Carboplatin 89 Pemetrexed 65 Paclitaxel 50 Erlotinib Hydrochloride 46 Cisplatin 46 Radiotherapy 45 Docetaxel 37 Gemcitabine 34 Bevacizumab 32 pembrolizumab 25 Nivolumab 23 Radiosurgery 18 Etoposide 18 durvalumab 12 Cetuximab 12 Ipilimumab 11 Albumin-Bound Paclitaxel 10 Vinorelbine 9 Taxes 9 Gefitinib 9 Radiation 8 Magnetic Resonance Spectroscopy 8 osimertinib 7 Specimen Handling 7 Platinum 7 Cyclophosphamide 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 vandetanib 6 epacadostat 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡